SCHEMBL22548207

SCHEMBL22548207

CSN1CCN(C(=O)CNC(=O)OCc2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PREP P48147 2/20 0.51
▸ SIGMAR1 Q99720 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CTSL P07711 1/20 0.46
▸ CTSB P07858 1/20 0.46
▸ CTSS P25774 1/20 0.46
▸ CTSK P43235 1/20 0.46
▸ FNTA P49354 1/20 0.45
▸ FNTB P49356 1/20 0.45
▸ HTT P42858 1/20 0.44
▸ KEAP1 Q14145 1/20 0.43
▸ NFE2L2 Q16236 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7159251 0.90 PREP (0.59) PREPSIGMAR1ALDH1A1OPRK1LMNA
SCHEMBL11263011 0.90 PREP (0.59) PREPSIGMAR1ALDH1A1OPRK1LMNA
SCHEMBL27795955 0.86 PREP (0.56) PREPSIGMAR1ALDH1A1OPRK1LMNA
SCHEMBL8253758 0.84 PREP (0.60) PREPALDH1A1OPRK1LMNASMN1; SMN2
SCHEMBL8750837 0.84 PREP (0.60) PREPSIGMAR1ALDH1A1OPRK1LMNA
SCHEMBL2586953 0.84 L3MBTL1 (0.61) PREPALDH1A1SMN1; SMN2GAAL3MBTL1
SCHEMBL7683566 0.84 GAA (0.54) PREPSIGMAR1ALDH1A1OPRK1LMNA
SCHEMBL8249773 0.83 PREP (0.59) PREPALDH1A1OPRK1LMNASMN1; SMN2
SCHEMBL5873672 0.82 GAA (0.55) PREPSIGMAR1ALDH1A1OPRK1LMNA
SCHEMBL22548206 0.82 ALDH1A1 (0.61) PREPSIGMAR1ALDH1A1OPRK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020210662-A1 SMALL MOLECULES FOR CANCER THERAPY THAT REDUCE THE EXPRESSION OF TRANSCRIPTION FACTORS KLF5 AND EGR-1 THE SCRIPPS RESEARCH INSTITUTE (US) 2020-10-15 — — WO disclosed
Send feedback